RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/30565858http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30565858http://www.w3.org/2000/01/rdf-schema#comment"This study was designed to detecting the influences of lncRNA MEG3 in prostate cancer. Aberrant lncRNAs expression profiles of prostate cancer were screened by microarray analysis. The qRT-PCR and Western blot were employed to investigating the expression levels of lncRNA MEG3, miR-9-5p and QKI-5. The luciferase reporter assay was utilized to testifying the interactions relationship among these molecules. Applying CCK-8 assay, wound healing assay, transwell assay and flow cytometry in turn, the cell proliferation, migration and invasion abilities as well as apoptosis were measured respectively. LncRNA MEG3 was a down-regulated lncRNA in prostate cancer tissues and cells and could inhibit the expression of miR-9-5p, whereas miR-9-5p down-regulated QKI-5 expression. Overexpressed MEG3 and QKI-5 could decrease the abilities of proliferation, migration and invasion in prostate cancer cells effectively and increased the apoptosis rate. On the contrary, miR-9-5p mimics presented an opposite tendency in prostate cancer cells. Furthermore, MEG3 inhibited tumour growth and up-regulated expression of QKI-5 in vivo. LncRNA MEG3 was a down-regulated lncRNA in prostate cancer and impacted the abilities of cell proliferation, migration and invasion, and cell apoptosis rate, this regulation relied on regulating miR-9-5p and its targeting gene QKI-5."xsd:string
http://purl.uniprot.org/citations/30565858http://purl.org/dc/terms/identifier"doi:10.1111/jcmm.13658"xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/author"Chen T."xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/author"Huang Y."xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/author"Wu M."xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/author"Wang W."xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/author"Yang S."xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/author"Ye Z."xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/author"Xi X."xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/name"J Cell Mol Med"xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/pages"29-38"xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/title"LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis."xsd:string
http://purl.uniprot.org/citations/30565858http://purl.uniprot.org/core/volume"23"xsd:string
http://purl.uniprot.org/citations/30565858http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/30565858
http://purl.uniprot.org/citations/30565858http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/30565858
http://purl.uniprot.org/uniprot/#_B4DHR6-mappedCitation-30565858http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30565858
http://purl.uniprot.org/uniprot/#_Q8WY44-mappedCitation-30565858http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30565858
http://purl.uniprot.org/uniprot/#_Q96PU8-mappedCitation-30565858http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30565858
http://purl.uniprot.org/uniprot/B4DHR6http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/30565858
http://purl.uniprot.org/uniprot/Q8WY44http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/30565858
http://purl.uniprot.org/uniprot/Q96PU8http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/30565858